Jump to main content
Jump to site search


Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer

Abstract

Precise diagnosis and effective treatment are crucial to the prognosis of pancreatic ductal adenocarcinoma (PDAC). Magnetic iron oxide nanoparticles (IONPs) are superior magnetic resonance imaging (MRI) contrast agents, meanwhile antibodies are significant immunotherapy reagent. Herein, we firstly generated a novel nanocomposite combining triple single chain antibodies (scAbs) and IONPs for the detection and treatment of PDAC. Methods: Triple scAbs (scAbMUC4, scAbCEACAM6, scFvCD44v6, MCC triple scAbs) were conjugated to the surface of polyethylene glycol modified IONPs (IONPs-PEG), forming the IONPs-PEG-MCC triple scAbs nanocomposite. Characterization, cytotoxicity, specificity, and apoptosis induction of the nanocomposite were evaluated. In vivo MRI study and anti-pancreatic cancer effect assessment were performed through tumor-bearing nude mice. Results: The size of IONPs-PEG-MCC triple scAbs was about 23.6 nm. The nanocomposite was non-toxic to normal pancreatic ductal epithelial cells, and could specifically bind to and be internalized by MUC4/CEACAM6/CD44v6-expressing PDAC cells. With a r2 relaxivity of 104.2 mM−1 s−1, IONPs-PEG-MCC triple scAbs could significantly shorten MRI T2-weighted signal intensity both in vitro and in vivo. IONPs-PEG-MCC triple scAbs also showed favorable anti-pancreatic cancer effect. Conclusion: In present study, IONPs-PEG-MCC triple scAbs was firstly confirmed as a bi-functional nanocomposite in both MRI and treatment, providing its critical clinical transformation potential in PDAC detection and treatment.

Back to tab navigation

Supplementary files

Article information


Submitted
11 Jun 2019
Accepted
11 Jan 2020
First published
13 Jan 2020

Nanoscale, 2020, Accepted Manuscript
Article type
Paper

Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer

J. Zou, S. Chen, Y. Li, L. Zeng, G. Lian, J. Li, S. Chen, K. Huang and Y. Chen, Nanoscale, 2020, Accepted Manuscript , DOI: 10.1039/C9NR04976B

Social activity

Search articles by author

Spotlight

Advertisements